Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2247996rdf:typepubmed:Citationlld:pubmed
pubmed-article:2247996lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2247996lifeskim:mentionsumls-concept:C0021641lld:lifeskim
pubmed-article:2247996lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:2247996lifeskim:mentionsumls-concept:C0439836lld:lifeskim
pubmed-article:2247996lifeskim:mentionsumls-concept:C0851827lld:lifeskim
pubmed-article:2247996lifeskim:mentionsumls-concept:C1701901lld:lifeskim
pubmed-article:2247996pubmed:issue15lld:pubmed
pubmed-article:2247996pubmed:dateCreated1991-1-10lld:pubmed
pubmed-article:2247996pubmed:abstractTextAfter a circa 10-year therapy with MC-insulin NOVO 12 diabetics were changed to the chromatographically purified insulins L-insulin S.N.C. and insulin S.N.C. of the nationally-owned enterprise Berlin-Chemie. 3 and 6 months, respectively, ago after the ambulatory change the patients were metabolically, immunologically, hormonally and clinically characterized. Profiles of blood glucose, value of glycaemia and HbA1 also lipid parameters, creatinine values, residual B-cell function, blood pressure and ophthalmologic state did not show any significant differences to the initial values after change to S.N.C.-insulins. Insulin-antibody level (9.5%-9.4%-9.7%) and insulin need (0.48 IU/kg-0.46 IU/kg-0.48 Iu/kg) also remained unchanged. Local reactions were not observed. Under the condition of a permanently good quality of the S.N.C.-insulins (purity and stability of the preparations) the application of chromatographically purified insulin of the firm Berlin-Chemie with comparable therapeutic success as in insulin MC NOVO is possible in a large part of the patients.lld:pubmed
pubmed-article:2247996pubmed:languagegerlld:pubmed
pubmed-article:2247996pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2247996pubmed:citationSubsetIMlld:pubmed
pubmed-article:2247996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2247996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2247996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2247996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2247996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2247996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2247996pubmed:statusMEDLINElld:pubmed
pubmed-article:2247996pubmed:monthAuglld:pubmed
pubmed-article:2247996pubmed:issn0044-2542lld:pubmed
pubmed-article:2247996pubmed:authorpubmed-author:RatzmannK PKPlld:pubmed
pubmed-article:2247996pubmed:authorpubmed-author:HildebrandtRRlld:pubmed
pubmed-article:2247996pubmed:authorpubmed-author:ZieheHHlld:pubmed
pubmed-article:2247996pubmed:authorpubmed-author:ZieheSSlld:pubmed
pubmed-article:2247996pubmed:issnTypePrintlld:pubmed
pubmed-article:2247996pubmed:day1lld:pubmed
pubmed-article:2247996pubmed:volume45lld:pubmed
pubmed-article:2247996pubmed:ownerNLMlld:pubmed
pubmed-article:2247996pubmed:authorsCompleteYlld:pubmed
pubmed-article:2247996pubmed:pagination460-3lld:pubmed
pubmed-article:2247996pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:meshHeadingpubmed-meshheading:2247996-...lld:pubmed
pubmed-article:2247996pubmed:year1990lld:pubmed
pubmed-article:2247996pubmed:articleTitle[Experiences with conversion from MC-insulin NOVO to L-insulin S.N.C. of insulin dependent diabetic patients].lld:pubmed
pubmed-article:2247996pubmed:affiliationZentralstelle für Diabetes und Stoffwechselkrankheiten, Berlin.lld:pubmed
pubmed-article:2247996pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2247996pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2247996pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2247996pubmed:publicationTypeEnglish Abstractlld:pubmed